Tandem Diabetes Care, Inc. - ROE
TNDM
Price:
$15.3
Market Cap:
$1.05B
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based ap...[Read more]
Industry
Medical - Devices
IPO Date
2013-11-14
Stock Exchange
NASDAQ
Ticker
TNDM
PE Ratio
[-11.17]
ROE
[-68.29%]
Current Ratio
[3.58]
Dividend Yield
[0%]
Enterprise Value
[1.60B]
Dividend History
The ROE as of June 2026 (TTM) for Tandem Diabetes Care, Inc. (TNDM) is -68.29%
According to Tandem Diabetes Care, Inc.’s latest financial reports and current stock price. The company's current ROE is -68.29%. This represents a change of 284.64% compared to the average of -17.75% of the last 4 quarters.
Tandem Diabetes Care, Inc. (TNDM) Historical ROE (quarterly & annually)
How has TNDM ROE performed in the past?
The mean historical ROE of Tandem Diabetes Care, Inc. over the last ten years is 128.57%. The current -68.29% ROE has changed -153.11% with respect to the historical average. Over the past ten years (40 quarters), TNDM's ROE was at its highest in in the March 2017 quarter at 1.27%. The ROE was at its lowest in in the September 2016 quarter at -573.68%.
Average
128.57%
Median
-17.10%
Minimum
-131.93%
Maximum
1.41%
Tandem Diabetes Care, Inc. (TNDM) ROE by Quarter and Year
Discovering the peaks and valleys of Tandem Diabetes Care, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 261.46%
Maximum Annual ROE = 1.41%
Minimum Annual Increase = -1333.91%
Minimum Annual ROE = -131.93%
| Year | ROE | Change |
|---|---|---|
| 2025 | -131.93% | 261.46% |
| 2024 | -36.50% | -48.58% |
| 2023 | -70.98% | 230.11% |
| 2022 | -21.50% | -698.26% |
| 2021 | 3.59% | -138.29% |
| 2020 | -9.39% | -26.07% |
| 2019 | -12.70% | -86.41% |
| 2018 | -93.40% | -137.28% |
| 2017 | 250.56% | -82.20% |
| 2016 | 1.41% | -1333.91% |
Tandem Diabetes Care, Inc. (TNDM) Average ROE
How has TNDM ROE performed in the past?
The current ROE of Tandem Diabetes Care, Inc. (TNDM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-79.80%
5-year avg
-51.46%
10-year avg
128.57%
Tandem Diabetes Care, Inc. (TNDM) ROE vs. Peers
How is TNDM’s ROE compared to its peers?
Tandem Diabetes Care, Inc.’s ROE is greater than Integra LifeSciences Holdings Corporation (-47.65%), greater than Kodiak Sciences Inc. (-253.85%), greater than Nurix Therapeutics, Inc. (-64.21%), less than InMode Ltd. (13.28%), less than UroGen Pharma Ltd. (121.52%), greater than EyePoint Pharmaceuticals, Inc. (-110.54%), greater than Septerna, Inc. (-9.44%), less than Phathom Pharmaceuticals, Inc. (39.24%), greater than Tango Therapeutics, Inc. (-41.54%), greater than Fortrea Holdings Inc. (-79.12%),
| Company | ROE | Market cap |
|---|---|---|
| -47.65% | $1.37B | |
| -253.85% | $1.91B | |
| -64.21% | $1.52B | |
| 13.28% | $814.84M | |
| 121.52% | $1.64B | |
| -110.54% | $1.14B | |
| -9.44% | $1.63B | |
| 39.24% | $867.74M | |
| -41.54% | $3.48B | |
| -79.12% | $1.45B |
Build a custom stock screener for Tandem Diabetes Care, Inc. (TNDM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tandem Diabetes Care, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Tandem Diabetes Care, Inc. (TNDM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Tandem Diabetes Care, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Tandem Diabetes Care, Inc.'s ROE?
How is the ROE calculated for Tandem Diabetes Care, Inc. (TNDM)?
What is the highest ROE for Tandem Diabetes Care, Inc. (TNDM)?
What is the 3-year average ROE for Tandem Diabetes Care, Inc. (TNDM)?
What is the 5-year average ROE for Tandem Diabetes Care, Inc. (TNDM)?
How does the current ROE for Tandem Diabetes Care, Inc. (TNDM) compare to its historical average?